Wednesday, January 26, 2022 - 13:00:47
|
Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing | Industry Analysis | Market Size | 2030
The Novel Immuno-Oncology / Cancer Biomarker Testing market is anticipated to grow at an annualized rate of ~18% over the next decade
Wednesday, July 28, 2021, 13:52, 7 Months Ago
in
Health
|
|||
|
|
Biologics Fill Finish Service Providers Market (2nd Edition) | Industry Analysis | Market Size | 2030
With a current capacity of 3.5 million liters, the biologics fill/finish services market is equiped to handle future demand, growing at a healthy CAGR of ~10%
Monday, July 12, 2021, 12:54, 7 Months Ago
in
Health
|
|||
|
|
Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (5th Edition) | Industry Analysis | Market Size | 2030
The T-cell immunotherapy (CAR-T, TCR, and TIL) market is projected to grow at an annualized rate of over 41.5% during the time period 2019-2030
Monday, July 12, 2021, 10:24, 7 Months Ago
in
Health
|
|||
|
|
Diabetes Monitoring Devices Market report features an extensive study of the current landscape and the future opportunities associated...
Tuesday, July 6, 2021, 14:12, 7 Months Ago
in
Business
|
|||
|
|
Research report on the future opportunity of targeted protein degradation therapeutics and technology platforms
Wednesday, June 30, 2021, 14:45, 7 Months Ago
in
Business
|
|||
|
|
Market research report on prefilled syringe (PFS) fill / finish services; with a focus on current market landscape and future growth opportunities
Wednesday, June 30, 2021, 12:54, 8 Months Ago
in
Health
|
|||
|
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment
London
Roots Analysis has announced the addition of the “Microbial Contract Bio manufacturing Market, 2020-2030” report to its list of offerings.
Despite...
Tuesday, June 29, 2021, 13:35, 8 Months Ago
in
Business
|
|||
|
Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth, till 2030
London
Roots Analysis has announced the addition of “Gene Therapy Market 2020-2030” report to its list of offerings.
Success of approved gene therapies has...
Tuesday, June 29, 2021, 12:31, 8 Months Ago
in
Business
|
|||
|
Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion-dollar cancer immunotherapy market
London
Roots Analysis has announced the addition of “CAR-T Cell Therapies Market by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute...
Monday, June 28, 2021, 15:18, 8 Months Ago
in
Business
|
|||
|
|
Market research report focused on companion diagnostics service providers; details include current market landscape and future growth opportunities
Monday, June 28, 2021, 13:10, 8 Months Ago
in
Health
|
|||
|
|
Digital Solutions for Biomarkers Market report features an extensive study of the current landscape and the likely future potential of single-use systems..
Tuesday, May 18, 2021, 10:59, 9 Months Ago
in
News
|
|||
|
Roots Analysis has announced the addition of “Digital Solutions for Biomarkers Market, 2021-2030” report to its list of offerings.
Digital solutions for biomarkers are modern solutions that are capable of generating, collecting, and tracking medical data. From this data, digital biomarkers that offer insights into anatomical, physiological, and molecular events, and even behavior-related patterns in...
Tuesday, May 18, 2021, 10:58, 9 Months Ago
in
Health
|